Treatment Intensification Prior to Radical Prostatectomy for Clinically Localized Prostate Cancer
Cancers · 07.07.2025 · 17 (13) · 2258
DOI: 10.3390/cancers17132258 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 07.07.2025. Verfasst von Carlos Jesus Perez Kerkvliet und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Current guidelines recommend either radical prostatectomy (RP) or radiation with androgen deprivation therapy (ADT) for unfavorable intermediate- or high-risk prostate cancer. There has been emerging interest in the potential benefits of neoadjuvant ADT prior to RP for this population. Past trials indicate neoadjuvant ADT may be associated with reduced surgical complexity, pathologic downstaging, decreased positive margins, and decreased rates of nodal positivity, although they have not shown benefits for cancer progression and survival. Accordingly, neoadjuvant ADT is currently not recommended for surgical patients. Conversely, ADT is a mainstay of treatment in metastatic disease, and interest remains in expanding its use towards patients with clinically localized disease. There are several ongoing trials of second-generation androgen blockers such as enzalutamide, darolutamide, radiopharmaceuticals, and poly (ADP-ribose) polymerase (PARP) inhibitors to explore long-term cancer-specific survival benefits with neoadjuvant use. In this narrative review, we provide a comprehensive overview of the recent literature and ongoing efforts to incorporate neoadjuvant therapy for clinically localized prostate cancer patients who are at high-risk of recurrence after prostatectomy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
- Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA 10107, USA.
ORCID-Profile: Rasheed A M Thompson, William Kevin Kelly, Mihir Shah
Zitieren
APA
Perez Kerkvliet, C. J., Leong, J. Y., Thompson, R. A. M., Zarrabi, K. K., Kelly, W. K., Lallas, C., Gomella, L., & Shah, M. (2025). Treatment Intensification Prior to Radical Prostatectomy for Clinically Localized Prostate Cancer. Cancers, 17(13), 2258. https://doi.org/10.3390/cancers17132258
Vancouver
Perez Kerkvliet CJ, Leong JY, Thompson RAM, Zarrabi KK, Kelly WK, Lallas C, et al. Treatment Intensification Prior to Radical Prostatectomy for Clinically Localized Prostate Cancer. Cancers. 2025;17(13):2258. doi:10.3390/cancers17132258
BibTeX
@article{PerezKerkvliet2025,
author = {Perez Kerkvliet, Carlos Jesus and Leong, Joon Yau and Thompson, Rasheed A M and Zarrabi, Kevin Kayvan and Kelly, William Kevin and Lallas, Costas and Gomella, Leonard and Shah, Mihir},
title = {Treatment Intensification Prior to Radical Prostatectomy for Clinically Localized Prostate Cancer},
journal = {Cancers},
year = {2025},
volume = {17},
number = {13},
pages = {2258},
doi = {10.3390/cancers17132258}
}
EUVIMED